drugset / Trial / NCT01684891
A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers
Non-randomizedSingle-groupOpen-label
Summary
This is a single-center, open label, multiple dose study to investigate the pharmacokinetics of RG1662 given twice daily over 28 days, and in addition, the excretion and metabolism of \[13C\]-labeled IV microdoses and an oral \[14C\]-labeled dose of RG1662 in healthy male volunteers. The anticipated time of study treatment is 4 weeks.
Timeline
- Start
- 2012-09
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Basmisanil | Small molecule | — | — |
Indications
No indication recorded.